Genoox, the world's first community-driven genomic data platform, has raised $8 million in a round led by IN Venture, a Sumitomo Corporation backed venture fund, with participation from Infinity Medical and existing investors Inimiti, Glilot Capital and Triventures, the company announced Tuesday.
Follow Israel Hayom on Facebook and Twitter
The new investment will enable the company to expand its community of genetic professional users, reaching over 1,500 healthcare organizations today, enhancing the network effect created by sharing genetic insights on the Genoox platform.
"With thousands of genomic professional users around the globe our community is rapidly growing and helping the genetic medical community bridge the gap in clinical care. Genoox is proud to be the catalyst of such an important effort," said Genoox co-founder and CEO Amir Trabelsi.
IN Venture managing partner Eitan Naor said, "Our investment in Genoox is a clear reflection of our belief that genomic data will become the backbone of the precision medicine revolution … Genoox's deep-tech and unique approach to building a world-class community of users has created an incredibly rich data platform, which in turn holds a profound opportunity for making new clinical discoveries."
Additionally, the company announced that veteran technology executive and digital health innovator Ohad Arazi has been appointed chairman of the board.
